Moleculin Biotech

MBRX

Börsenwert 8,26 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Vanguard Group Malvern, Pennsylvania	3,35 Mio. $	+2,28 Mio. $	+42	+233 %
2	2 Renaissance Technologies New York	1,04 Mio. $	+869.649 $	+16	+533 %
3	3 Whitegate Investment Counselors Concord, New Hampshire	190.000 $	–	–	–
4	4 Truist Financial Charlotte, North Carolina	175.000 $	–	–	–
5	5 Geode Capital Management Boston, Massachusetts	158.000 $	–	–	–
6	6 BlackRock New York	141.000 $	+108.706 $	+2	+200 %
7	7 Northern Trust Chicago, Illinois	60.000 $	–	–	–
8	8 Bank of New York Mellon New York	41.000 $	–	–	–
9	9 Morgan Stanley New York	39.000 $	+54.353 $	+1	Neu
10	10 Raymond James Financial Services Advisors St. Petersburg, Florida	24.000 $	–	–	–
11	11 Dimensional Fund Advisors Austin, Texas	21.000 $	–	–	–
12	12 Susquehanna International Group Bala Cynwyd, Pennsylvania	20.000 $	–	–	–
13	13 Laird Norton Wetherby Wealth Management San Francisco, California	13.000 $	–	–	–
14	14 Commonwealth Equity Services Waltham, Massachusetts	12.000 $	–	–	–
15	15 Archford Capital Strategies Swansea, Illinois	4.000 $	–	–	–
16	16 Country Trust Bank Bloomington, Illinois	3.000 $	–	–	–
17	17 Patriot Financial Group Insurance Agency Westborough, Massachusetts	3.000 $	–	–	–
18	18 Wells Fargo San Francisco, California	3.000 $	–	–	–
19	APA 19 American Portfolios Advisors Holbrook, New York	2.500 $	–	–	–
20	20 Carson Wealth (CWM LLC) Omaha, Nebraska	1.000 $	–	–	–
21	21 Global Retirement Partners San Rafael, California	1.000 $	–	–	–
22	22 Prestige Wealth Management Group Flemington, New Jersey	1.000 $	–	–	–
23	23 Royal Bank of Canada Toronto, Ontario, Canada	1.000 $	–	–	–
24	24 CVI Holdings Wilmington, Delaware	–	-294.000 $	-8	Geschlossen
25	25 Armistice Capital New York	–	-179.000 $	-5	Geschlossen

Moleculin Biotech MBRX Börsenwert 8,26 Mio. $

Moleculin Biotech

MBRX

Börsenwert 8,26 Mio. $